Use of Wearable Activity Tracker in Patients With Cancer Undergoing Chemotherapy: Toward Evaluating Risk of Unplanned Health Care Encounters.
Tanachat NilanonLuciano P NoceraAlexander S MartinAnand KolatkarMarcella MayZaki HasnainNaoto Tada UenoSriram YennuAngela AlexanderAaron E MejiaRoger Wilson BolesMing LiJerry S H LeeSean E HanlonFrankie A Cozzens PhilipsDavid I QuinnPaul K NewtonJoan E BroderickCyrus ShahabiPeter KuhnJorge J NievaPublished in: JCO clinical cancer informatics (2021)
The use of a wearable activity tracker is generally feasible in a similar population of patients with cancer. A larger randomized controlled trial should be conducted to confirm the association between lower nonsedentary hours and higher UHEs.